Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 2;397(10268):68-70.
doi: 10.1016/S0140-6736(20)32175-9. Epub 2020 Oct 27.

The UK Government's Vaccine Taskforce: strategy for protecting the UK and the world

Kate Bingham  1
Affiliations
Review

The UK Government's Vaccine Taskforce: strategy for protecting the UK and the world

Kate Bingham. Lancet. .
No abstract available

PubMed Disclaimer

References

    1. Office for National Statistics Analysis of deaths involving COVID-19 data. July 17, 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarri...
    1. Centers for Disease Control and Prevention Provisional death counts for coronavirus disease 2019 (COVID-19): daily updates of totals by week and state. https://www.cdc.gov/nchs/nvss/vsrr/COVID19/index.htm
    1. Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396:467–478. - PMC - PubMed
    1. Walsh EE, Frenck RW, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020 doi: 10.1056/nejmoa2027906. published online Oct 14. - DOI - PMC - PubMed
    1. Sadoff J, Le Gars M, Shukarev G, et al. Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial. medRxiv. 2020 doi: 10.1101/2020.09.23.20199604. published online Sept 25. (preprint) - DOI

Substances